You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

Article metrics

Article menu

Download PDFPDF

Oral Plenary
Plenary V
IGCS20_1271
14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2020 to April 2024

AbstractFullPdf
Nov 20202007
Dec 20204207
Jan 20211304
Feb 2021504
Mar 202117010
Apr 202121011
May 2021603
Jun 2021207
Jul 20211011
Aug 2021006
Sep 2021008
Oct 202113021
Nov 202122018
Dec 20214705
Jan 20221700
Feb 20222003
Mar 20222604
Apr 20222607
May 202229011
Jun 20221204
Jul 20224202
Aug 20222006
Sep 20222405
Oct 20222005
Nov 20221201
Dec 20222504
Jan 20233501
Feb 20231702
Mar 20231401
Apr 2023602
May 2023401
Jun 2023801
Jul 20233009
Aug 20231604
Sep 2023201
Oct 20233007
Nov 20231802
Dec 20234600
Jan 20241402
Feb 2024803
Mar 202421039
Apr 20241206
Total7630255